In addition to our work in diabetes, a major driver of cardiovascular disease, we also work extensively in the prevention of Atrial Fibrillation (AF), which contributes to one in five strokes in the UK and is associated with greater disability and mortality that non AF-related strokes.

It is estimated that up to 500,000 people in the UK have undiagnosed AF, and with an ageing population, it is predicted that the number of people aged >55 years living with AF will more than double by 2060.

We work with local CCGs and providers to support improved detection of AF in the population, improve the quality of life of adults with atrial fibrillation, promote initiation of appropriate anticoagulant therapies in those at risk of stroke and optimise anticoagulation therapy to ensure maximum reduction in stroke risk with minimum risk of bleeding and allow patients to be involved in decision making as per NICE guidance (QS93 July 2015).

Explore our projects supporting better cardiovascular health.

We're here to help

Want to know more about our cardiovascular support offer?

Get in touch